Core Scientific (CORZ) grants 138,547 RSUs to executive

Rhea-AI Filing Summary

DUCHENE TODD M reported acquisition or exercise transactions in this Form 4 filing.

Core Scientific, Inc. reported that officer Todd M. Duchene received an annual grant of 138,547 shares of common stock in the form of restricted stock units on May 20, 2026, at no purchase price. One-third of these RSUs will vest on March 15, 2027, with the remaining two-thirds vesting in eight substantially equal quarterly installments thereafter, as long as he continues serving the company on each vesting date. Following this equity award, Duchene directly holds 2,098,895 shares of Core Scientific common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DUCHENE TODD M

Role See remarks

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	138,547	$0.00	--

Holdings After Transaction: Common Stock — 2,098,895 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 138,547 shares Grant price per share: $0.00 per share Shares held after transaction: 2,098,895 shares +2 more

5 metrics

RSU grant size 138,547 shares Annual restricted stock unit grant on May 20, 2026

Grant price per share $0.00 per share Stated price for RSU award

Shares held after transaction 2,098,895 shares Total direct holdings following RSU grant

Initial vesting portion One-third of 138,547 RSUs Vests on March 15, 2027, subject to continued service

Remaining vesting schedule Two-thirds in 8 installments Vests in eight substantially equal quarterly installments after March 15, 2027

Key Terms

restricted stock unit ("RSU"), vest, quarterly installments

3 terms

restricted stock unit ("RSU") financial

"Represents an annual restricted stock unit ("RSU") grant."

vest financial

"One-third of the RSUs will vest on March 15, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

quarterly installments financial

"remaining two-thirds of the RSUs will vest in eight substantially equal quarterly installments thereafter"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DUCHENE TODD M

(Last) (First) (Middle)

C/O CORE SCIENTIFIC, INC.

838 WALKER ROAD, SUITE 21-2105

(Street)

DOVER DELAWARE 19904

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		A		138,547(1)	A	$0	2,098,895	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an annual restricted stock unit ("RSU") grant. One-third of the RSUs will vest on March 15, 2027, and the remaining two-thirds of the RSUs will vest in eight substantially equal quarterly installments thereafter, provided that the Reporting Person continues to provide service to the Issuer on each vesting date.

Remarks:

Chief Legal and Administrative Officer

	/s/ Todd DuChene	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CORZ report for Todd M. Duchene?

Todd M. Duchene received an annual equity award of 138,547 restricted stock units (RSUs) of Core Scientific common stock. The grant was priced at $0.00 per share, reflecting a compensation award rather than a market purchase for cash.

How and when do Todd M. Duchene’s new CORZ RSUs vest?

One-third of Duchene’s 138,547 RSUs will vest on March 15, 2027. The remaining two-thirds will vest in eight substantially equal quarterly installments after that date, conditioned on his continued service with Core Scientific at each vesting date.

How many Core Scientific (CORZ) shares does Todd M. Duchene hold after this grant?

After the RSU award, Duchene directly holds 2,098,895 shares of Core Scientific common stock. This total includes the newly granted RSUs, which will convert into shares as they vest over time according to the disclosed vesting schedule.

Was cash paid for Todd M. Duchene’s 138,547 CORZ RSU grant?

No cash was paid for this award; the RSUs were granted at a stated price of $0.00 per share. This indicates a compensation-related equity grant rather than an open-market stock purchase using personal funds.

What type of compensation did Core Scientific (CORZ) use in this Form 4 filing?

Core Scientific used restricted stock units (RSUs) as equity compensation, granting 138,547 RSUs to officer Todd M. Duchene. RSUs are promises to deliver shares in the future as they vest, aligning compensation with ongoing service and company performance.